by In2Pharma | Mar 30, 2026 | News
Belgium On 5 March 2026, an introductory session on the new FAMHP platform for the management of GDP inspections took place. As promised, we hereby provide you with an update on the implementation of this platform. Please find below some key information: As of April...
by In2Pharma | Feb 13, 2026 | News
Belgium The FAMHP will launch a new platform for managing GDP inspections which will replace the current method. An introduction session will be organized by the FAMHP to present the new platform. The platform will be used, among other things, to send inspection...
by In2Pharma | Mar 14, 2024 | News
Belgium As previously announced, since 9th of Feb 2024, Belgium and Luxembourg switched to a full EU-FMD implementation. The Belgian NCA (FAGG / AFMPS / FAMHP) now published Circular 654 for the attention of the inspectors involved in the control of the distribution...
by In2Pharma | Apr 14, 2017 | News
EU The European Commission and the United States Food and Drug Administration (FDA) have updated the EU-US 1998 Mutual Recognition Agreement (MRA). According to this amendment, the EU and US regulatory authorities now mutually recognize inspections of pharmaceutical...
